Last reviewed · How we verify
Leuprolide Oral Tablet 10-mg BID — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Leuprolide Oral Tablet 10-mg BID (Leuprolide Oral Tablet 10-mg BID) — Enteris BioPharma Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Leuprolide Oral Tablet 10-mg BID TARGET | Leuprolide Oral Tablet 10-mg BID | Enteris BioPharma Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Leuprolide Oral Tablet 10-mg BID CI watch — RSS
- Leuprolide Oral Tablet 10-mg BID CI watch — Atom
- Leuprolide Oral Tablet 10-mg BID CI watch — JSON
- Leuprolide Oral Tablet 10-mg BID alone — RSS
Cite this brief
Drug Landscape (2026). Leuprolide Oral Tablet 10-mg BID — Competitive Intelligence Brief. https://druglandscape.com/ci/leuprolide-oral-tablet-10-mg-bid. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab